Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
NCT03316807
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
182
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B Vaccine
Interventions
BIOLOGICAL:
60 µg dose hepatitis B vaccine
BIOLOGICAL:
20 µg dose hepatitis B vaccine
Sponsor
Suping Wang
Collaborators
[object Object]